Search Within

Population Sciences Research Program

  1. "Cancer Research"
  2. "Katherine Panageas"
Formats
  1. Meeting Abstract (9)
  2. Journal Article (3)
Groups
  1. Biostatistics Service (12)
  2. Epidemiology and Biostatistics (12)
  3. Department of Medicine (10)
  4. GSK Faculty (9)
  5. Solid Tumor Oncology Division (9)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)

More Groups

People
  1. Katherine Panageas (12)
  2. Jedd Wolchok (4)
  3. Paul Chapman (4)
  4. Brooke Mastrogiacomo (3)
  5. Gregory Riely (3)
  6. Jessica Lavery (3)

More People

Years
  1. 2023 (1)
  2. 2021 (2)
  3. 2020 (1)
  4. 2014 (1)
  5. 2013 (1)
  6. 2012 (1)

More Years

Publications
  1. Cancer Research (12)
Publishers
  1. American Association for Cancer Research (12)

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Analysis and visualization of longitudinal genomic and clinical data from the AACR Project GENIE Biopharma Collaborative in cBioPortal
    Journal Article

    de Bruijn, I.; Kundra, R.; Mastrogiacomo, B.; Tran, T. N.; Sikina, L.; Mazor, T.; Li, X.; Ochoa, A.; Zhao, G.; Lai, B.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Defining real-world recurrence in the AACR Project GENIE Biopharma Collaborative Data
    Meeting Abstract

    Lavery, J. A.; Brown, S.; Lepisto, E.; Lenoue-Newton, M. L.; McCarthy, C.; Rizvi, H.; Yu, C.; Kehl, K. L.; Sweeney, S. M.; Rudolph, J. E.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Ignoring left truncation in overall survival within real-world genomic-phenomic data leads to inflated survival estimates
    Meeting Abstract

    Brown, S.; Lavery, J. A.; Lepisto, E. M.; McCarthy, C.; Rizvi, H.; Yu, C.; Kehl, K. L.; Sweeney, S. M.; Rudolph, J. E.; Schultz, N.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Overcoming immune resistance with rationally designed combination immunotherapy
    Meeting Abstract

    Zappasodi, R.; Budhu, S.; Sirard, C.; Qi, J.; Liu, C.; Li, Y.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Zhong, H.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • NRAS mutation as a predictor of response to immune-based therapies in patients with metastatic melanoma
    Meeting Abstract

    Iams, W. T.; Johnson, D. B.; Flavin, M.; Panageas, K.; Ayers, G. D.; Zhao, Z. G.; Iafrate, A. J.; Sullivan, R. J.; Carvajal, R. D.; Sosman, J. A.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Phase II trial of MEK inhibitor selumetinib (AZD6244) in patients with BRAFV600E/K- or NRAS-mutated melanoma
    Meeting Abstract

    Catalanotti, F.; Solit, D. B.; Pulitzer, M. P.; Berger, M. F.; Scott, S. N.; Iyriboz, T.; Lacouture, M. E.; Panageas, K. S.; Wolchok, J. D.; Carvajal, R. D.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Prevalence and effects of off-label use of chemotherapeutic agents in elderly breast cancer patients: Estimates from Surveillance, Epidemiology and End Results Medicare data
    Meeting Abstract

    Eaton, A. A.; Sima, C. S.; Panageas, K. S.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Safety and immunogenicity of gp100 DNA vaccines in patients with melanoma
    Meeting Abstract

    Yuan, J.; Ku, G. Y.; Gallardo, H. F.; Orlandi, F.; Manukian, G.; Rasalan, T.; Li, H.; Xu, Y.; Vyas, S.; Mu, Z.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Pilot study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma
    Meeting Abstract

    Perales, M. A.; Yuan, J.; Powel, S.; Gallardo, H. F.; Rasalan, T. S.; Gonzalez, C.; Manukian, G.; Wang, J.; Zhang, Y.; Chapman, P. B.; more...
    Cancer Research (2008)

    Fulltext@MSK | Save
  • Clinical significance of BRAF or NRAS mutations in metastatic melanoma
    Meeting Abstract

    Chang, D. Z.; Panageas, K. S.; Osman, I.; Polsky, D.; Chapman, P. B.
    Cancer Research (2004)

    Fulltext@MSK | Save